Mediators of Inflammation

Mediators of Inflammation / 2009 / Article

Clinical Study | Open Access

Volume 2009 |Article ID 125152 | 11 pages | https://doi.org/10.1155/2009/125152

Perforin Expression in Peripheral Blood Lymphatic Cells of Patients Subjected to Laparoscopic or Open Cholecystectomy

Academic Editor: Magdalena Klink
Received09 Oct 2008
Revised02 Feb 2009
Accepted03 Mar 2009
Published07 May 2009

Abstract

Perforin-(P-) related characteristics of cytotoxic T lymphocytes and natural killer cells were investigated in peripheral blood of patients subjected to open (OC; ) or laparoscopic cholecystectomy (LC; ) and healthy controls ( ). Blood samples were obtained preoperatively and 24 hours after the surgeries, and the data were correlated with the intensity of cholestasis and concomitant inflammation, determined by functional hepatic tests. Postoperative differences were found to be minimal: OC decreased only the percentage of cells, while LC decreased the fraction of cells and augmented the mean fluorescence intensity of P in CD56 cells. Patients elected for OC had, however, higher preoperative numbers of total , , and cells than patients elected for LC and healthy controls, while both groups of patients, preoperatively, had lower fraction of and cells. These changes were in high correlation with blood concentrations of CRP, AP, and ALT, emphasizing the link between the preoperative cholestasis and inflammation and P-dependent cytotoxic mechanisms.

1. Introduction

Since its introduction in the late 1980s, laparoscopic cholecystectomy (LC) has been used as a “gold standard” for management of symptomatic gallstone disease, replacing almost completely the open cholecystectomy (OC) [13]. It is commonly followed by less pain, shorter hospitalization, and faster recovery owing to the reduced magnitude of the initial surgical insult and lower systemic immune impairment [4]. However, positive CO2 pneumoperitoneum, abdominal wall distention, and peritoneal acidosis may activate the additional factors that affect the outcome of operations, leading to both the potentiation of surgical trauma [4, 5], and the beneficial immune-modulating effect, linked with the augmentation of IL-10, attenuation of TNF production [68], and diminishing effect on surgery-induced imbalance in pro-/anti-inflammatory cytokines [9, 10]. Cellular mechanisms underlying these effects are, however, very complex, since surgical manipulation or pneumoperitoneum and laparotomy may alter the expression of 116 and 398 splenic T-cell genes, respectively, that might be involved in signal transduction, chemotaxis, and cell cycle of lymphocytes [11].

In the present study, we tried to analyze the perioperative changes in cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells after LC and OC, since, particularly, these cells are involved in immune surveillance and have the crucial roles in the prevention or attenuation of disease through their ability to eliminate infected or transformed cells [1215]. Their cytoplasm is rich in granules composed of complexes of proteoglycan in association with the pore-forming protein perforin (P) and a family of serine proteinases, known as granzymes that are released into the intercellular space on interaction of NK cells or CTL with a target cell. Whether granzyme entry into the target cell cytoplasm occurs directly after perforin pore formation in the plasma membrane or after endosomolysis is still debated [1215]. According to the original model, P acts by forming a cell membrane pore through which granzymes pass into the target cell, where they cleave specific substrates that initiate DNA fragmentation and caspase-dependent or caspase-independent apoptotic cell death. However, more recently, it was proposed that granzymes might be endocytosed independently of P and that P acts to release granzymes that are sequestered in endosomes into the cytosol of the target cell. In addition, there is a possibility that P triggers Ca2+ influx, which may activate rapid coendocytosis of granzymes and P into giant endosomes, followed by P-mediated release of granzymes to the cytosol [1215].

In circulating nonactivated lymphocytes, cytotoxicity is restricted to NK cells, / TCR+ T cells, and a subpopulation of CD8+ cells, which constitutively express perforin but its expression can be induced in many CD4+, MHC class II restricted CTL, in CD8+ CTL as well as in CD4lowCD25highFoxP3+ T regulatory cells [1215]. Moreover, the expression of P in T cells might be a useful marker for functionally activated cytotoxic cells in situ [12].

Trying to determine the early postoperative effects of classic and laparoscopic cholecystectomy on these events, in this study we analyzed the P content in the PBMNLC before and 24 hours after the operations. Furthermore, in an attempt to link these events with the intensity of preoperative cholestasis and inflammation induced by gallstones, we correlated these data with the blood concentrations of acute phase proteins and markers of cholestasis, such as bilirubin (BIL), alkaline phosphatase (AP), and hepatic enzymes. The data showed that perforin-dependent cytotoxic mechanisms are only moderately affected by different types of operations, but that the preoperative cholestasis and hepatic injury may significantly increase the number of peripheral blood cells containing the perforin.

2. Patients and Methods

2.1. Patients

In a prospective, nonrandomized study that was approved by Ethical Committee of Medical faculty, University of Rijeka, we analyzed the immune functions of 23 patients submitted to conventional, open cholecystectomy (OC) and 21 patients undergoing laparoscopic cholecystectomy (LC) for symptomatic cholecystolithiasis. Mean age for the conventional group was 61.8 years (range 31 to 85) for 13 women and 10 men. For LC, mean age was 55.5 years (range 28 to 82); this group consisted of 13 women and 8 men. Laparoscopic cholecystectomy was carried out in a standardized technique using 4 troacars and a pneumoperitoneum of 14 mm Hg. Open cholecystectomy was performed through a right subcostal incision. General anesthesia was the same in both groups. Mean operative duration was 90 minutes (range 74–139) for OC and 120 minutes (range 90–150), for LC without statistically significant difference, showing that the two groups were comparable for the demographic and surgery-related parameters (Table 1).


Classic cholecystectomyPLaparoscopic cholecystectomy

Number of patients2321
Ratio Female/male 13/10 13/8
Age-mean   (min-max) 61.8 (31–85) 0.23 n.s. 55.5 (28–82)
Duration of anesthesia (min) 90 (74–130) 0.38 n.s. 120 (90–150)
Duration of operation (min) 65 (35–120) 0.45 n.s. 90 (40–150)

There were also no statistically significant differences in the standard hematological parameters, such as red and white cells counts, hematocrit, and platelets (not shown) but group of patients chosen for classic cholecystectomy had significantly greater preoperative cholestasis (Figure 1), since laparoscopic cholecystectomy with insufflations of CO2 was avoided in patients with chronic cholecystolithiasis. Therefore, this group of patients had significantly higher levels of total bilirubin (57.6 versus 13.1  mol/L, ), AP (216.4 versus 64.0 IU/L; ), GGT 273.03 versus 28.96 IU/L; ), AST (56.3 versus 24.4; ), ALT (95.42 versus 28.9 IU/L; ), as well as the higher levels of CRP (28.57 versus 4,84 mg/L; ) in comparison with group chosen for laparoscopic cholecystectomy.

In both groups, the patients with acquired or inherited immunodeficiencies and those who developed postoperative complications were excluded from the study. Blood samples were collected preoperatively and on postoperative day 1 and tested for hematological and immunological parameters. Twenty healthy persons, consisting of laboratory personnel and blood volunteer donors (10 females and 10 males), corresponding by age and sexes to the examined patients groups were also studied.

2.2. Lymphocyte Preparation

Heparinized venous blood (10 mL) was diluted and separated on Lymphoprep (Nycomed Pharmaas, Oslo, Norway) for 20 minutes on 800 G. Cells accumulating at the interface were washed twice in RPMI 1640 and resuspended at a final concentration of peripheral blood lymphocytes per sample in fluorescent-activated cell sorting (FACS) buffer. Viability was assessed by trypan blue and was always around 98%.

2.3. Monoclonal Antibodies (MoAbs)

For staining of surface markers on human T and NK cells, the following phycoerythrin-(PE)- conjugated MoAb, obtained from Becton Dickinson (Mountain View) were used: anti-CD3, anti-CD4, anti-CD8, anti-CD16, and anti-CD56). For the detection of intracellular perforin a murine antihuman perforin MoAb G9 (MoAb; IgG2b) was purified from Balb/c ascites [16].

2.4. Simultaneous Measurement of Cell Surface (CD Markers) and Intracellular Antigen (Perforin) by Flow Cytometry

The method for the simultaneous detection of perforin (intracellular antigen) and cell surface antigens is described in detail elsewhere [17]. Briefly, peripheral blood mononuclear cells (PBMNLC) were aliquoted (106 per aliquot) and washed in FACS buffer, then fixed in 100  L PBS containing 4% paraformaldehyde, pH 7.4, for 10 minutes at room temperature. After two washes in FACS buffer, the cells were permeabilized with saponin buffer (0.1% saponin) (Sigma, Poole, Dorset) for 20 min at room temperature. Murine monoclonal antibody reacting with human perforin (P) MoAb-G9 (IgG2b, purified from Balb/c ascites) was added to the suspension of cells in saponin, at final concentration of 8–10  g per sample and incubated for 30 minutes at room temperature. All further steps, secondary antibody, FITC-conjugated goat-antimouse Ig (Becton Dickinson, San Jose, Calif, USA), and rising procedures were performed in Saponin buffer. Cells surface antigens (CD3, CD4, CD8, CD16, and CD56) were then stained in FACS buffer at a final concentration of monoclonal antibody of 10  g/mL (Becton Dickinson) and 100  L were added to the pelleted cells. After 30-minutes incubation at +4°C, cells were washed with FACS buffer and stained with avidin-phycoerythrin (20  g/mL, Becton Dickinson) for 30 min. An irrelevant isotype-matched murine MoAb was used as a negative control. A minimum of 104 cells was analyzed on FACScan (Becton Dickinson).

2.5. Liver Functional Tests

The standard preoperative workup for predicting choledocholithiasis in both group of patients included liver function tests and abdominal ultrasound. Liver transaminases (ALT, AST), liver cholestasis tests (gamma-glutamyl transpeptidase-GGT, and alkaline phosphatase-ALP) and liver clearance tests (total and conjugated bilirubin-BIL) were determined by enzymatic calorimetric methods, using routine laboratory techniques with Roche reagents in a Roche-Hitachi Modular-P800 clinical chemistry module (Roche, Mannhein, Germany).

2.6. Statistical Analysis

Statistical significance was calculated by two-tailed Student's t-test for paired samples, and by Mann-Whitney U-test for the evaluation of differences between the groups. Test of correlation and linear regression analyses were made by statistical software Statistics for Windows, Kernel release 5.5 (StatSoft, Inc., Tulsa, OK). Linear regression equations were generated using a Pearson-Product moment correlation and analyzed for differences of covariance. values of .05 or less were considered statistically significant. Data are reported as mean SEM or as median values, with 25th–75th percentiles in parentheses.

3. Results

Immune status of patients undergoing classic, open (OC), or laparoscopic (LC) cholecystectomy was evaluated before and 24 hours after the operations. Comparison of the data was then made between the pre- and postoperative values in the same group, between the preoperative values in the OC and LC groups as well as between the preoperative values in groups of patients elected for operations and the control group, consisting of healthy blood donors of corresponding age. Analysis included standard determination of surface antigens on lymphatic cells and two color analysis, with simultaneous determination of surface markers and intracellular content of perforin.

3.1. Peripheral Blood Lymphocyte Subpopulations in Patients Undergoing to Open or Laparoscopic Cholecystectomy

Standard immunological tests revealed that preoperative numbers of T lymphocytes (CD3+, CD4+, and CD8+) and NK cells (CD16+ and CD56+) in both groups were in normal ranges for healthy, adult people. Furthermore, no differences were found in preoperative values of both T (Figure 2(a)) and NK cells (Figure 2(b)) in blood of patients elected for OC and LC groups as well as in the postoperative values of all T lymphocytes and CD16+ NK cells. Classic cholecystectomy, however, slightly decreased the percentage of CD56+ NK cells (18.7% versus 15.4%; ), as shown on Figure 2(b).

3.2. Perforin Positive Peripheral Blood Lymphocytes

Data were then analyzed by double labeling of CD surface marker and perforin and presented as a fraction of total peripheral blood lymphocytes containing perforin (TP+ cells) and as a percentage of double positive T (Figure 3(a)) or NK cells (Figure 3(b)).

The significant postoperative difference was found only after LC, which decreased the fraction of cytotoxic CD8+P+ cells from 13.5 to 10.2% ( ), as it is presented on Figure 3(a) and on representative histogram (Figure 3(c)), showing perforin expression on the gated CD8+ T cells, before and after LC.

Comparison with healthy control revealed, however, that preoperative values of TP+ and CD3+P+ cells in patients elected for OC were significantly higher than normal values (30.78% and 16.05% versus 27.3% and 10,68%, resp.; ) (Figure 3(a)), as well as that all patients elected for operations had, preoperatively, lower fractions of perforin positive NK cells (Figure 3(b)), since in OC group CD16+P+  cell fraction fell from 20.16% to 14.14% ( ) and CD56+P+  cells from 20.74% to 13.63% ( ) and in LC group to 10.71% ( ) and to 11.64% ( ), respectively.

Increased expression of perforin in T cells (CD3+P+ and CD4+P+) and lower expression of perforin in NK cells (CD16+P+) in preoperative blood of patients elected for classic cholecystectomy versus control subjects are presented also by the representative density plots (Figure 4(a) and 4(b), resp.).

3.3. Level of Perforin Protein Expression in T and NK Cell Subsets

The procedure of double labeling of peripheral blood lymphocytes by flow cytometry permitted also the measurement of mean fluorescence intensity (MFI), which correlates with a number of perforin molecules present in the cells [17]. By applying standard parameters for FSC, SSC, FL1 and FL2, we thus, analyzed MFI for perforin in subsets of T lymphocytes (CD3+P+, CD4+P+, CD8+P+) and NK cells (CD16+P+ and CD56+P+). As presented on Figure 5(b) and on representative histogram (Figure 5(c)) we noticed slight upregulation of perforin content only after LC in CD56+P+cells ( ). The data, however, clearly showed that lymphatic subpopulation (CD3, CD4, CD16 and CD56) of patients undergoing the classic cholecystectomy contained, preoperatively, the higher quantities of perforin in their granules in comparison with patients selected for LC (Figures 5(a), 5(b), and 6).

3.4. Correlation between the Intensity of Preoperative Cholestasis and Presence of Perforin-Expressing Cells

The findings of the marked changes in the proportions and MFI of perforin-expressing cells in preoperative blood suggested that these events might be related with the previously described greater cholestasis and inflammation in patients elected for classic cholecystectomy (Figure 1). To test this possibility the concentrations of CRP, hepatic enzymes and bilirubin in preoperative sera of all patients undergoing to the operations were, individually, in each person correlated with the percentage of perforin positive cells and with MFI for perforin in lymphocytes subpopulations found in preoperative samples of blood.

It was found (Figure 7) that concentration of CRP was in a very high positive correlation with percentage of total number of perforin positive cells ( ; ), CD3+P+ ( ; ) and the fraction of P+ cells among CD4+ subset of cells ( ; ) as well as in the negative correlation with the fraction of P+ cells among CD16+ cells ( ; ).

The data (Figure 8) revealed also the presence of positive correlation between the concentration of AP in serum and proportion of CD4+P+ cells ( ; ) as well as the presence of negative correlation between AP and proportion of P+ cells among the CD8+ cells ( ; ), and between the concentration of total bilirubin and proportion of P+ cells in CD8+ cells ( ; ).

However, although these data suggested that cholestasis and inflammation have induced a switch in immune response toward the CD4+P+ cells, it was also found that higher concentrations of ALT in sera increased the MFI of perforin in CD16+ ( ; ) and CD56+ cells ( ; ), suggesting that remaining NK cells, owing to the increased content of P probably obtained a higher cytotoxic activity (Figure 9).

4. Discussion

Trying to contribute to the elucidation of profound immunological dysfunctions induced by surgical trauma [111] and mechanisms that regulate the P expression in cytolytic cells [1215], in this study we analyzed primarily the changes in perforin expressing peripheral blood lymphatic cells after OC and LC. The data showed that in early postoperative period, the type of operation minimally affected the P-related events, since only LC decreased the percentage of circulating CD8+P+ cells (Figures 3(a), 3(c)) and increased the MFI of perforin in CD56+ cells (Figures 5(b), 5(c)), suggesting that the pneumoperitoneum with insufflations of CO2 had a stimulating effect on cytolytic activity of NK cells and contributed to distribution of CTL in the tissue. Changes might be related with lower operative stress, extracellular acidification or selective activation of different macrophage subpopulation [111] but need further characterization, particularly, owing to our findings that immune outcome of cholecystectomy might be markedly influenced by the intensity of preoperative inflammation and cholestasis. In our study this, obviously, influenced the number of perforin expressing cells in both groups of patients since they, preoperatively, had significantly lower proportions of CD16+P+ and CD56+P+ cells (Figures 3(b) and 4(b)). Similarly, augmented proportions of TP+ cells, CD3+P+ cells and CD4+P+ cells (Figures 3(a) and 4(a)) were found in patients elected for OC, which preoperatively, had higher preoperative levels of CRP, AP, B, AST and ALT (Figure 1), suggesting that preoperative inflammation and cholestasis affected the perforin-related events. The hypothesis was confirmed by linear regression analyses, made in all patients elected for the operations, which clearly showed that the concentration of CRP in the serum was in high positive correlation with the percentage of TP+ cells, CD3+ P+ and CD4+P+ cells and in negative correlation with the fraction of P+ cells among the CD16+ NK cells (Figure 7). Moreover, an additional effect of cholestasis was confirmed by finding of positive correlation between AP in the serum and fraction of CD4+P+ cells, and negative correlation of both AP and bilirubin with fraction of P+ cells among CD8+ cells (Figure 8). Taken together, the data imply that, in patients with gallstones, the inflammation and chronic cholelithiasis had particularly stimulated the generation of cytotoxic CD4+P+ cells, decreasing simultaneously the circulating levels of CD8+P+ T cells and CD16+P+ NK cells (Figures 3, 4, 6, and 7), probably owing to their greater homing into the insulted liver tissue. However, based on the fact that ALT was in high positive correlation with MFI of perforin in CD16+ and CD56+ cells (Figure 9), we speculated also that hepatic injury might increased the content of perforin per cell in remaining circulating NK cells.

The data are in high agreement with current knowledge about the influence of inflammation and injuries on cytotoxic cells of innate [18, 19] and adaptive immunity [20, 21] and point to the liver as an important organ for maintenance of self-tolerance and elimination of potentially dangerous cells that arose during the cholestasis and hepatic damages in patients with gallstones. The mechanisms are unclear, since the consequences of obstructive jaundice are complex and involve a number of immune effectors that contribute to a variety of immunological derangements [22, 23] as well as to hepatic regeneration [24, 25] and fibrosis  [26]. In this context it could be speculated that destruction of intrahepatic bile ducts or the appearance of aberrant cholangiocytes has initially stimulated the intrahepatic NK cells, leading to cholangiocyte killing and apoptosis by the granzyme/perforin pathway or by activation of death receptors belonging to the tumor necrosis factor (TNF) receptor superfamily and TRAIL, as it was reported in the bile duct-ligated mice [27] and in patients with the primary biliary cirrhosis, where the activation of hepatic NK cells led to exacerbated damage on liver tissues [23, 28, 29]. Noteworthy, higher cytotoxicity might be induced by activation of several classes of killer lectin-like receptors (e.g., NKG2D and natural cytotoxicity receptors), that are commonly expressed by human NK cells as well as by TCR and TCR CD8+ T lymphocytes and specifically interact with stress-inducible molecules, such as MICA, MICB, and ULBP, which might be displayed by “stressed” or “altered” self cells and by virus-infected cells [30]. Furthermore, since cholestatic jaundice is often followed by bacteriemia [22, 23], for our data showing the correlation of CD4+P+ cells with the serum levels of CRP and AP (Figures 7 and 8) might be relevant that in inflammatory bowel diseases with uncontrolled immune responses to bacterial flora were found CD4 (+) NKG2D (+) T-cell clones that were involved in perforin-mediated killing of the targets expressing MICA [31].

It should be, however, emphasized that CD4+P+ cells T cells, activated in the liver, might belong also to CD4+NKT cells or to CD4+CD25+ regulatory T cells, since these autoreactive T cells clones also participate in perforin-mediated killing. The former, which might be activated by glycolipid antigens, are characterized also by rapid activation and secretion of large amounts of numerous types of cytokines that in turn interact with a multitude of other cell types [3235], while the latter are known to participate in the control of autoantigen recognition and the development of autoreactive T cells clones, by mechanisms that include direct killing of cytotoxic cells through cell-to-cell contact, inhibition of cytokine production by cytotoxic cells and direct secretion of immunomodulatory cytokines, such as TGF- and interleukin-10 [3639], acting together with other CD4+ cells as crucial regulators of adaptive and innate immune responses [40].

In conclusion, our data show that in early postoperative period only laparoscopic cholecystectomy moderately affected perforin-expressing cells in peripheral blood, decreasing the percentage of CD8+P+ cells and increasing the content of perforin in CD56+  cells. However, pointing to the complexity of physiological and immunological derangements induced by cholelitiasis and obstructive jaundice, we also show that preoperative cholestasis and hepatic injury, might have a marked influence on perforin-related aspects of cytotoxic T and NK cells and final interpretation of data obtained by classic or laparoscopic cholecystectomy.

Abbreviations

ALT:Alanine amino-transferase
AP:Alkaline phosphatase
AST:Aspartate amino-transferase
MFI:Mean fluorescence intensity
CRP:C-reactive protein
CTL:Cytotoxic T lymphocytes
BIL:Direct bilirubin
GGT:Gamma-glutamyl transpeptidase
IL-6:Interleukin-6
LC:Laparoscopic cholecystectomy
NK:Natural killer cells
NKT:Natural killer T cells
OC:Open cholecystectomy
P:Perforin
PBMCs:Peripheral blood mononuclear cells
Treg:Regulatory T cells
TNF-alpha:Tumor necrosis factor alpha.

Acknowledgment

This work was supported by a grant from the Croatian Ministry of Science (Project no. 62-0621341-1337). Professors Harry Grbas and Ines Mrakovčić-Šutič equally contributed to this work.

References

  1. C. K. McSherry, “Open cholecystectomy,” The American Journal of Surgery, vol. 165, no. 4, pp. 435–439, 1993. View at: Publisher Site | Google Scholar
  2. B. C. Visser, R. W. Parks, and O. J. Garden, “Open cholecystectomy in the laparoendoscopic era,” American Journal of Surgery, vol. 195, no. 1, pp. 108–114, 2008. View at: Publisher Site | Google Scholar
  3. A. Gupta and D. I. Watson, “Effect of laparoscopy on immune function,” British Journal of Surgery, vol. 88, no. 10, pp. 1296–1306, 2001. View at: Publisher Site | Google Scholar
  4. J. F. Larsen, P. Ejstrud, F. Svendsen, V. Pedersen, and F. Redke, “Systemic response in patients undergoing laparoscopic cholecystectomy using gasless or carbon dioxide pneumoperitoneum: a randomized study,” Journal of Gastrointestinal Surgery, vol. 6, no. 4, pp. 582–586, 2002. View at: Publisher Site | Google Scholar
  5. H. Gebhardt, A. Bautz, M. Ross, D. Loose, H. Wulf, and H. Schaube, “Pathophysiological and clinical aspects of the CO2 pneumoperitoneum (CO2-PP),” Surgical Endoscopy, vol. 11, no. 8, pp. 864–867, 1997. View at: Publisher Site | Google Scholar
  6. E. J. Hanly, A. A. Aurora, S. P. Shih et al., “Peritoneal acidosis mediates immunoprotection in laparoscopic surgery,” Surgery, vol. 142, no. 3, pp. 357–364, 2007. View at: Publisher Site | Google Scholar
  7. J. M. Fuentes, E. J. Hanly, A. R. Aurora et al., “CO2 abdominal insufflation pretreatment increases survival after a lipopolysaccharide-contaminated laparotomy,” Journal of Gastrointestinal Surgery, vol. 10, no. 1, pp. 32–38, 2006. View at: Publisher Site | Google Scholar
  8. E. J. Hanly, M. Mendoza-Sagaon, K. Murata, J. M. Hardacre, A. De Maio, and M. A. Talamini, “CO2 pneumoperitoneum modifies the inflammatory response to sepsis,” Annals of Surgery, vol. 237, no. 3, pp. 343–350, 2003. View at: Publisher Site | Google Scholar
  9. I. B. Brune, W. Wilke, T. Hensler, B. Holzmann, and J.-R. Siewert, “Downregulation of T helper type 1 immune response and altered pro- inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery,” The American Journal of Surgery, vol. 177, no. 1, pp. 55–60, 1999. View at: Publisher Site | Google Scholar
  10. N. N. Choileain and H. P. Redmond, “Cell response to surgery,” Archives of Surgery, vol. 141, no. 11, pp. 1132–1140, 2006. View at: Publisher Site | Google Scholar
  11. P. Sylla, A. Nihalani, and R. L. Whelan, “Microarray analysis of the differential effects of open and laparoscopic surgery on murine splenic T-cells,” Surgery, vol. 139, no. 1, pp. 92–103, 2006. View at: Publisher Site | Google Scholar
  12. E. R. Podack, V. Deyev, and M. Shiratsuchi, “Pore formers of the immune system,” Advances in Experimental Medicine and Biology, vol. 598, pp. 325–341, 2007. View at: Publisher Site | Google Scholar
  13. D. Kägi, P. Seiler, J. Pavlovic et al., “The roles of perform- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses,” European Journal of Immunology, vol. 25, no. 12, pp. 3256–3262, 1995. View at: Publisher Site | Google Scholar
  14. S. P. Cullen and S. J. Martin, “Mechanisms of granule-dependent killing,” Cell Death and Differentiation, vol. 15, no. 2, pp. 251–262, 2008. View at: Publisher Site | Google Scholar
  15. I. Voskoboinik, M. J. Smyth, and J. A. Trapani, “Perforin-mediated target-cell death and immune homeostasis,” Nature Reviews Immunology, vol. 6, no. 12, pp. 940–952, 2006. View at: Publisher Site | Google Scholar
  16. A. Hameed, K. J. Olsen, L. Cheng, W. M. Fox III, R. H. Hruban, and E. R. Podack, “Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody,” American Journal of Pathology, vol. 140, no. 5, pp. 1025–1030, 1992. View at: Google Scholar
  17. D. Rukavina, G. Laskarin, G. Rubesa et al., “Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells,” Blood, vol. 92, no. 7, pp. 2410–2420, 1998. View at: Google Scholar
  18. A. Moretta, E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta, “NK cells at the interface between innate and adaptive immunity,” Cell Death & Differentiation, vol. 15, no. 2, pp. 226–233, 2008. View at: Publisher Site | Google Scholar
  19. M. J. Smyth, E. Cretney, J. M. Kelly et al., “Activation of NK cell cytotoxicity,” Molecular Immunology, vol. 42, no. 4, pp. 501–510, 2005. View at: Publisher Site | Google Scholar
  20. M. H. Andersen, D. Schrama, P. thor Straten, and J. C. Becker, “Cytotoxic T cells,” Journal of Investigative Dermatology, vol. 126, no. 1, pp. 32–41, 2006. View at: Publisher Site | Google Scholar
  21. M. Barry and R. C. Bleackley, “Cytotoxic T lymphocytes: all roads lead to death,” Nature Reviews Immunology, vol. 2, no. 6, pp. 401–409, 2002. View at: Google Scholar
  22. L. Nehéz and R. Andersson, “Compromise of immune function in obstructive jaundice,” European Journal of Surgery, vol. 168, no. 6, pp. 315–328, 2002. View at: Publisher Site | Google Scholar
  23. I. R. Mackay, “Autoimmune diseases of the liver, autoimmune hepatitis and primary biliary cirrhosis: unfinished business,” Hepatology Research, vol. 37, supplement 3, pp. S357–S364, 2007. View at: Publisher Site | Google Scholar
  24. N. Fausto, J. S. Campbell, and K. J. Riehle, “Liver regeneration,” Hepatology, vol. 43, supplement 1, pp. S45–S53, 2006. View at: Publisher Site | Google Scholar
  25. Z. Dong, H. Wei, R. Sun, and Z. Tian, “The roles of innate immune cells in liver injury and regeneration,” Cellular and Molecular Immunology, vol. 4, no. 4, pp. 241–252, 2007. View at: Google Scholar
  26. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at: Publisher Site | Google Scholar
  27. A. Kahraman, F. J. Barreyro, S. F. Bronk et al., “TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse,” Hepatology, vol. 47, no. 4, pp. 1317–1330, 2008. View at: Publisher Site | Google Scholar
  28. C. Selmi, M. Zuin, and M. E. Gershwin, “The unfinished business of primary biliary cirrhosis,” Journal of Hepatology, vol. 49, no. 3, pp. 451–460, 2008. View at: Publisher Site | Google Scholar
  29. D. Vergani and G. Mieli-Vergani, “Aetiopathogenesis of autoimmune hepatitis,” World Journal of Gastroenterology, vol. 14, no. 21, pp. 3306–3312, 2008. View at: Publisher Site | Google Scholar
  30. Y. Hayakawa and M. J. Smyth, “NKG2D and cytotoxic effector function in tumor immune surveillance,” Seminars in Immunology, vol. 18, no. 3, pp. 176–185, 2006. View at: Publisher Site | Google Scholar
  31. M. Allez, V. Tieng, A. Nakazawa et al., “CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions,” Gastroenterology, vol. 132, no. 7, pp. 2346–2358, 2007. View at: Publisher Site | Google Scholar
  32. M. Kronenberg and A. Rudensky, “Regulation of immunity by self-reactive T cells,” Nature, vol. 435, no. 7042, pp. 598–604, 2005. View at: Publisher Site | Google Scholar
  33. D. I. Godfrey, M. J. McConville, and D. G. Pellicci, “Chewing the fat on natural killer T cell development,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2229–2232, 2006. View at: Publisher Site | Google Scholar
  34. A. Bendelac, P. B. Savage, and L. Teyton, “The biology of NKT cells,” Annual Review of Immunology, vol. 25, pp. 297–336, 2007. View at: Publisher Site | Google Scholar
  35. M. G. Swain, “Hepatic NKT cells: friend or foe?” Clinical Science, vol. 114, no. 7-8, pp. 457–466, 2008. View at: Publisher Site | Google Scholar
  36. F. Ghiringhelli, C. Ménard, F. Martin, and L. Zitvogel, “The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression,” Immunological Reviews, vol. 214, no. 1, pp. 229–238, 2006. View at: Publisher Site | Google Scholar
  37. M. Giroux, E. Yurchenko, J. St-Pierre, C. A. Piccirillo, and C. Perreault, “T regulatory cells control numbers of NK cells and CD8α+ immature dendritic cells in the lymph node paracortex,” The Journal of Immunology, vol. 179, no. 7, pp. 4492–4502, 2007. View at: Google Scholar
  38. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at: Publisher Site | Google Scholar
  39. W. J. Grossman, J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley, “Human T regulatory cells can use the perforin pathway to cause autologous target cell death,” Immunity, vol. 21, no. 4, pp. 589–601, 2004. View at: Publisher Site | Google Scholar
  40. A. La Cava, L. Van Kaer, and Fu-Dong-Shi, “CD4+CD25+ Tregs and NKT cells: regulators regulating regulators,” Trends in Immunology, vol. 27, no. 7, pp. 322–327, 2006. View at: Publisher Site | Google Scholar

Copyright © 2009 Harry Grbas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

887 Views | 408 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.